Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

This study has been terminated.

Study NCT00028483 Information provided by Seattle Genetics, Inc.

First Received: January 4, 2002 Last Updated: October 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2003
Estimated Primary Completion Date:	No date given